Prospective Evaluation of QPOP in Relapsed/ Refractory Non-Hodgkin’s Lymphoma
Treatment of relapsed/refractory non-Hodgkin’s lymphoma (R/R-NHL) remains one of the most difficult challenges in haematologic malignancies, with many patients exhausting standard therapies and facing limited treatment options. In a final […]